These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26449365)

  • 1. Routine antenatal anti-D prophylaxis: all change?
    Drug Ther Bull; 2015 Oct; 53(10):109. PubMed ID: 26449365
    [No Abstract]   [Full Text] [Related]  

  • 2. Rh-immunoglobulin: Rh prophylaxis.
    Bowman J
    Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 4. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 5. New test could help 40 000 pregnant rhesus D negative women avoid treatment, says NICE.
    Kmietowicz Z
    BMJ; 2016 Jul; 354():i3944. PubMed ID: 27422253
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing rhesus isoimmunization. Antepartum Rh immune globulin prophylaxis versus a sensitive test for risk identification.
    Hensleigh PA
    Am J Obstet Gynecol; 1983 Aug; 146(7):749-55. PubMed ID: 6307052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose of anti-D immunoglobulin for antenatal prophylaxis is smaller in the Netherlands than in the United Kingdom.
    van Dijk B
    BMJ; 1998 Oct; 317(7167):1253-4. PubMed ID: 9794881
    [No Abstract]   [Full Text] [Related]  

  • 8. Rh(D) haemolytic disease of the newborn: the changing scene.
    Urbaniak SJ
    Br Med J (Clin Res Ed); 1985 Jul; 291(6487):4-6. PubMed ID: 2990630
    [No Abstract]   [Full Text] [Related]  

  • 9. A case for the antenatal administration of anti-D immunoglobulin to primigravidae.
    Tovey LA; Taverner JM
    Lancet; 1981 Apr; 1(8225):878-81. PubMed ID: 6112301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The history of rhesus prophylaxis with anti-D.
    Wegmann A; Glück R
    Eur J Pediatr; 1996 Oct; 155(10):835-8. PubMed ID: 8891551
    [No Abstract]   [Full Text] [Related]  

  • 11. The prenatal use of RhO(D) immune globulin.
    Hammer RM; Bower EJ; Messina LJ
    MCN Am J Matern Child Nurs; 1984; 9(1):29-31. PubMed ID: 6422184
    [No Abstract]   [Full Text] [Related]  

  • 12. Antenatal anti-D prophylaxis.
    Bowman KM
    Lancet; 1980 Dec 20-27; 2(8208-8209):1372. PubMed ID: 6109187
    [No Abstract]   [Full Text] [Related]  

  • 13. Economics of antenatal prophylaxis.
    Cairns JA
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():19-22. PubMed ID: 9863974
    [No Abstract]   [Full Text] [Related]  

  • 14. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 15. Antenatal anti-D immunoglobulin.
    Lancet; 1983 Sep; 2(8352):734. PubMed ID: 6136859
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative.
    Chilcott J; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C; Tappenden P
    Health Technol Assess; 2003; 7(4):iii-62. PubMed ID: 12633527
    [No Abstract]   [Full Text] [Related]  

  • 17. Total prevention of Rh hemolytic disease: possible or impossible?
    Bowman JM
    Am J Pediatr Hematol Oncol; 1981; 3(3):323-30. PubMed ID: 6169290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R; Shokri F
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of haemolytic disease of the newborn due to anti-D.
    Tovey G; Wagstaff W
    Br Med J (Clin Res Ed); 1981 Jul; 283(6284):142. PubMed ID: 6266575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.